Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-03

Clinical Trial Update: Impact of Self-Monitoring Blood Glucose Frequency on Glycemic Control in Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 trial update evaluating whether different frequencies of self-monitoring blood glucose improve glycemic control in adults with Type 2 diabetes mellitu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: HealthPartners Institute | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED